What is the recommended management, including obtaining a bone density (DEXA) scan, for a 58-year-old female with bilateral shoulder pain and radiographic bone deterioration after unknown intramuscular injections?

Obtain a DEXA Scan Immediately

This 58-year-old postmenopausal woman with bilateral shoulder pain, radiographic bone deterioration, and a history of unknown intramuscular injections should undergo DXA (DEXA) scanning of the lumbar spine and hip(s) immediately to assess bone mineral density and evaluate for osteoporosis or steroid-induced bone loss 1.

Clinical Reasoning

Why DEXA is Essential Now

Your patient has multiple red flags that mandate bone density assessment:

• Postmenopausal status (58 years old) - already at baseline risk for osteoporosis
• Radiographic evidence of "bone deterioration" on shoulder X-rays - suggests possible systemic bone disease
• Unknown IM injections given alternating days × 3 - highly suspicious for corticosteroid therapy, which is a major risk factor for rapid bone loss and osteonecrosis 2, 3
• Bilateral shoulder involvement - raises concern for multifocal osteonecrosis, which can affect major joints sequentially over time 3

The Corticosteroid Concern

The pattern of alternating-day IM injections in Mexico strongly suggests corticosteroid therapy. This is critical because:

• Corticosteroid use is an independent risk factor for fracture beyond what bone density alone predicts 2
• Steroid-induced osteonecrosis can affect multiple joints progressively, including hips and shoulders, sometimes with delayed presentation over years 3
• Guidelines recommend lower treatment thresholds (T-score ≤-1.5 rather than -2.5) for patients on corticosteroids due to their elevated fracture risk 2

Recommended Imaging Protocol

Order: DXA lumbar spine and hip(s) 1

This is the standard screening examination and provides:

• T-scores to classify bone health (normal, osteopenia, or osteoporosis)
• Baseline for future monitoring if treatment is initiated
• Assessment of fracture risk at the two most clinically important sites

Additional Considerations for Shoulder Evaluation

While DEXA is the priority for systemic bone health assessment, the bilateral shoulder pain with radiographic abnormalities requires further characterization:

• If X-rays show focal bone lesions or collapse, consider MRI of both shoulders to evaluate for osteonecrosis (avascular necrosis) of the humeral heads 4, 3
• MRI without contrast is appropriate for assessing bone marrow changes, structural integrity, and associated soft tissue pathology 4
• The case report of sequential steroid-induced osteonecrosis affecting all four major joints (both hips and shoulders) over 13 years emphasizes the importance of bilateral imaging even if only one side is symptomatic 3

Management Algorithm Based on DEXA Results

If T-score ≤ -1.5 (given suspected steroid exposure):

• Initiate bisphosphonate therapy or other bone-protective treatment
• Obtain baseline vitamin D and calcium levels
• Ensure adequate calcium (1200 mg/day) and vitamin D (800-1000 IU/day) supplementation
• Consider endocrinology referral for optimization

If T-score between -1.0 and -1.5:

• Given the steroid exposure history, strongly consider treatment
• Repeat DEXA in 1-2 years if not treating
• Aggressive calcium and vitamin D supplementation

If T-score > -1.0:

• Reassess in 2 years
• Maintain calcium and vitamin D supplementation
• Address shoulder pathology separately

Critical Pitfalls to Avoid

1. Don't delay DEXA due to self-pay status - Osteoporosis screening is cost-effective and prevents devastating hip/spine fractures that are far more expensive to treat
2. Don't assume shoulder pain is purely mechanical - The combination of bilateral involvement and bone changes on X-ray suggests systemic pathology
3. Don't forget to image the contralateral shoulder - Steroid-induced osteonecrosis can be asymptomatic initially but progress to require joint replacement 3
4. Don't use shoulder X-rays alone - They may miss early osteonecrosis; MRI is superior for detecting marrow changes and structural damage 4

Cost Considerations for Self-Pay Patient

• DEXA scan typically costs $100-300 self-pay (much less than treating fractures)
• If DEXA shows osteoporosis, generic bisphosphonates (alendronate) are inexpensive (~$10-20/month)
• Early detection and treatment prevents fractures that cost tens of thousands of dollars

The investment in DEXA now is essential for this patient's long-term bone health and quality of life, particularly given the high suspicion for steroid-induced bone disease 1, 2.